Cefazolin Dosing in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass

NCT02749981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2023-05-18

No results posted yet for this study

Summary

Pharmacokinetics of cefazolin in children undergoing cardiac surgery.

Conditions

  • Cardiopulmonary Bypass

Interventions

PROCEDURE

blood and tissue sampling

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Katrien Francois, MD · Ghent University Hospital, Department of Cardiac Surgery

Eligibility

Min Age
0 Days
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2016-04-30
Completion
2016-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02749981 on ClinicalTrials.gov